IN2013MU02228AIN2228MU2013AIN2013MU02228AIN 2013MU02228 AIN2013MU02228 AIN 2013MU02228AIN 2228MU2013 AIN2228MU2013 AIN 2228MU2013AIN 2013MU02228 AIN2013MU02228 AIN 2013MU02228A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt LtdfiledCriticalWockhardt Ltd
Priority to IN2228MU2013priorityCriticalpatent/IN2013MU02228A/en
Publication of IN2013MU02228ApublicationCriticalpatent/IN2013MU02228A/en
forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents
Preparation methods for novel creation of biologically safe klh products used in cancer therapy, development of conjugated therapeutics and as challenge agents